2 days ago
ENGN
AnalystsYanan ZhuYanan Zhu's Stock Forecasts
AnalystsYanan Zhu
Sectors:
Analyst Ranking
Top 22%
#1226 out of 5558 analysts
Average Return
+5.28%
Win Rate
37%41 out of 110
Risk vs Reward
Poor
Good
Yanan Zhu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rapt Therapeutics IncRAPT | +486.85% | $9.81 | $57.57 | 2025-08-08 - 2026-01-20 | Strong Buy |
Regulus Therapeutics IncRGLS | +423.33% | $1.50 | $7.85 | 2025-03-27 - 2025-05-01 | Strong Buy |
Gracell Biotechnologies IncGRCL | +422.11% | $1.90 | $9.92 | 2023-03-27 - 2023-12-27 | Strong Buy |
Autolus Therapeutics PLCAUTL | +233.51% | $1.85 | $6.17 | 2023-03-27 - 2024-03-26 | Strong Buy |
Avidity Biosciences IncRNAM | +226.15% | $9.56 | $31.18 | 2024-01-03 - 2025-01-02 | Strong Buy |
Yanan Zhu Analyst Color
Get additional color on Yanan Zhu's coverage of popular stocks
a month ago
EDIT
a month ago
IOVA
2 months ago
PHVS
3 months ago
SYRE
6 months ago
CYTK
7 months ago
SYRE
10 months ago
TSHA
10 months ago
IONS
a year ago
RAPT
a year ago
RAPT
a year ago
QURE
a year ago
QURE
3 years ago
SYRE
3 years ago
IOVA
3 years ago
IOVA
3 years ago
BLUE
Yanan Zhu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Engene Therapeutics IncENGN | 3 | Strong Buy | $6.00 | +148.96% | Upgrades | 2 days ago |
Ionis Pharmaceuticals IncIONS | 6 | Strong Buy | $80.00 | +175.29% | Maintains | 4 days ago |
Fate Therapeutics IncFATE | 6 | Hold | $3.00 | +134.38% | Maintains | 8 days ago |
Beone Medicines LtdONC | 2 | Strong Buy | $435.00 | +4.43% | Maintains | 8 days ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $70.00 | +65.72% | Maintains | 10 days ago |
Kiniksa Pharmaceuticals International PLCKNSA | 1 | Strong Buy | $110.00 | +14.19% | Maintains | 17 days ago |
Editas Medicine IncEDIT | 8 | Strong Buy | $6.00 | +176.50% | Upgrades | a month ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $18.00 | +131.96% | Maintains | a month ago |
Cellectis SaCLLS | 1 | Hold | $3.00 | +154.24% | Maintains | 2 months ago |
Pharvaris NvPHVS | 2 | Strong Buy | $65.00 | +94.84% | Maintains | 2 months ago |
Scribe Therapeutics IncSCTX | 1 | Strong Buy | $60.00 | +266.75% | Initiates Coverage On | 3 months ago |
Metagenomi Therapeutics IncMGX | 6 | Strong Buy | $7.00 | +911.56% | Maintains | 3 months ago |
Spyre Therapeutics IncSYRE | 8 | Strong Buy | $115.00 | +10.58% | Maintains | 3 months ago |
Uniqure NvQURE | 8 | Strong Buy | $75.00 | +214.99% | Maintains | 3 months ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $105.00 | +87.07% | Maintains | 6 months ago |
Atrium Therapeutics IncRNA | 1 | Strong Buy | $25.00 | +232.89% | Initiates Coverage On | 8 months ago |
Intellia Therapeutics IncNTLA | 8 | Hold | $15.00 | +54.64% | Maintains | 8 months ago |
Sarepta Therapeutics IncSRPT | 8 | Strong Buy | $38.00 | +136.47% | Maintains | 9 months ago |
Arcellx IncACLX | 1 | Hold | $115.00 | -0.06% | Downgrades | 9 months ago |
Rapt Therapeutics IncRAPT | 8 | Hold | $58.00 | -0.03% | Downgrades | 10 months ago |
Taysha Gene Therapies IncTSHA | 4 | Strong Buy | $11.00 | +168.29% | Maintains | 10 months ago |
Arcturus Therapeutics Holdings IncARCT | 9 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Avidity Biosciences IncRNAM | 4 | Strong Buy | $75.00 | N/A | Maintains | a year ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Affimed NvAFMDQ | 7 | Hold | $0.10 | N/A | Downgrades | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Regulus Therapeutics IncRGLS | 2 | Hold | $9.00 | N/A | Downgrades | 2 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 7 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Sangamo Therapeutics IncSGMO | 3 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 1 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Alaunos Therapeutics IncTCRT | 1 | Strong Buy | $450.00 | N/A | Assumes | 4 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | $0.40 | N/A | Maintains | 4 years ago |
Argenx SeARGX | 1 | Hold | $326.00 | N/A | Maintains | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $52.50 | N/A | Downgrades | 6 years ago |
Chemocentryx IncCCXI1 | 1 | Strong Buy | $79.00 | N/A | Initiates Coverage On | 6 years ago |
Global Blood Therapeutics IncGBT | 4 | Strong Buy | $133.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.